Merck Stock Hits Record High on Sales of Cancer Drugs, Vaccines

Key TakeawaysMerck & Co. on Thursday reported a surprise adjusted profit for the fourth quarter as sales of its Keytruda cancer drug and Gardasil HPV vaccine soared.The pharmaceutical firm predicted better-than-expected full-year earnings per share.The news sent Merck shares to an all-time high in intraday trading Thursday.Merck & Co. (MRK) shares traded at an all-time high Thursday after the pharmaceutical company posted a surprisingly positive adjusted profit after sales jumped for its cancer drugs and va ...